Modified Light Conditions Enable Spirulina to Produce Bioavailable Vitamin B12 at Beef-Level Concentrations
Researchers led by Dr. Asaf Tzachor at Reichman University have successfully cultivated Spirulina that produces biologically active vitamin B12, overcoming a major nutritional limitation of the algae. By using photonic management to alter light conditions, the team created carbon-neutral biomass containing 1.64 micrograms of active B12 per 100 grams, a level comparable to or exceeding that found in beef. This is the first reported instance of bioavailable B12 in Spirulina, which traditionally contains only non-bioavailable pseudo-B12. The study, published in Discover Food, suggests that scaling this technology could provide significant amounts of the essential micronutrient, potentially addressing global deficiencies without the environmental costs of animal agriculture.
Key points
- The research team, including institutions from Iceland, Denmark, and Austria, utilized a biotechnology platform developed by VAXA Technologies in Iceland to modify the growth environment of Spirulina.
- The key innovation is photonic management, which changes the light conditions to encourage the production of biologically active vitamin B12 rather than the non-bioavailable pseudo-form typically found in conventional Spirulina.
- The resulting carbon-neutral biomass contained 1.64 micrograms of active vitamin B12 per 100 grams, compared to 0.7 to 1.5 micrograms per 100 grams in beef.
- The produced biomass also contained other bioactive compounds with antioxidant, anti-inflammatory, and immune-boosting properties.
- Scale-up projections indicate that reallocating electricity from heavy industry in Iceland could support the production of 277,950 tonnes of Spirulina annually, yielding enough active B12 to meet the daily requirements of over 13.8 million children aged 1-3.
- More ambitious scenarios suggest the technology could supply the recommended dietary allowance for over 50 million infants aged 0-6 months.
Background
Vitamin B12 deficiency affects over a billion people globally and is critical for red blood cell formation and nervous system function. While meat and dairy are primary sources, their production carries significant environmental costs. Previous coverage has highlighted that B12 deficiency can also arise from absorption issues unrelated to diet, such as those caused by proton pump inhibitors or pernicious anemia, and that elevated B12 levels may be associated with certain cancer outcomes, though causality remains unclear. Additionally, recent research has shown that bacteriophages can release B12 into microbial environments, influencing gut health. The current study addresses the supply side of B12 nutrition by attempting to make a plant-based source viable through biotechnological intervention.
Why it matters
This research offers a potential sustainable solution to a widespread nutritional deficiency by making a commonly available algae a reliable source of essential vitamins. If scaled, it could reduce dependence on animal agriculture for micronutrients while providing a carbon-neutral alternative. The findings demonstrate that biotechnology can alter the nutritional profile of microorganisms, potentially transforming how essential nutrients are produced and distributed globally.
What to watch
Further research and larger-scale production are required to determine how this technology can be integrated into real-world food systems. The current findings are based on exploratory studies and projections, so practical implementation and economic viability remain to be established.
Want the full story? Read the original reporting
Read on Science Daily